ArticleESMO open2024

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆.

A S Raghavendra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.